Subacute lesion volume as a potential prognostic biomarker for acute ischemic stroke after intravenous thrombolysis

J Neurol Sci. 2016 Oct 15:369:77-81. doi: 10.1016/j.jns.2016.08.006. Epub 2016 Aug 3.

Abstract

Background: The aim of this study was to identify whether subacute diffusion-weighted imaging (DWI) lesion volume could predict long-term outcome in patients who had undergone intravenous thrombolysis.

Method: Patients underwent DWI at baseline and 7days after thrombolysis. Outcomes included complete independence (modified Rankin scale [mRS] score 0 to 1), unfavorable outcome (mRS score 4 to 6) at 90days, and mortality within 90days. Multivariate logistic regression analysis was used to identify outcome predictors.

Results: Of 164 patients, 72 patients (43%) achieved complete independence. Poor outcomes were observed in 45 patients (27%) with an unfavorable outcome and 10 patients (6%) who died. Subacute DWI lesion volume was 3.4mL (interquartile range, 1.1-11.6) in patients with complete independence, 90.1mL (23.8-180.2) in patients with unfavorable outcome and 155.5mL (78.4-377.5) in patients who died. In multivariate logistic regression analysis, subacute DWI lesion volume was an independent predictor of complete independence (odds ratio [OR], 0.939; 95% confidence interval [CI], 0.914-0.965; p<0.001), unfavorable outcome (OR, 1.023; 95% CI, 1.014-1.033; p<0.001), and mortality (OR, 1.016; 95% CI, 1.005-1.028; p=0.005).

Conclusion: Subacute DWI lesion volume is a critical determinant of 90-day functional outcome and mortality after thrombolysis.

Keywords: Diffusion-weighted imaging; Ischemic stroke; Outcome; Tissue-type plasminogen activator.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / metabolism
  • Blood Glucose
  • Brain / diagnostic imaging
  • Brain / pathology*
  • Brain Ischemia / complications
  • C-Reactive Protein / metabolism
  • Diffusion Magnetic Resonance Imaging
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Glomerular Filtration Rate
  • Humans
  • Image Processing, Computer-Assisted
  • Injections, Intravenous
  • Male
  • Natriuretic Peptide, Brain / blood
  • ROC Curve
  • Retrospective Studies
  • Stroke / drug therapy*
  • Stroke / etiology
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome*

Substances

  • Biomarkers
  • Blood Glucose
  • Fibrinolytic Agents
  • Natriuretic Peptide, Brain
  • C-Reactive Protein
  • Tissue Plasminogen Activator